Digital
AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Articles
Demand grows for cancer R&D executives

Demand grows for cancer R&D executives

The recent acquisition of Norway's biotech frontrunner, Algeta, by Bayer for $2.9 billion, purchasing their exciting new prostate cancer drug Xofigo, has brought considerable attention on Oslo,

Sales & Marketing

Digital

Digital
AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D